Gil Leibowitz
-
- Diabetes Management and Research 8
- Surgery top 2%
- Pancreatic function and diabetes 38
- Physiology top 2%
- Cell Biology top 5%
- Endoplasmic Reticulum Stress and Disease 7
- Physiology top 5%
-
- Metabolism, Diabetes, and Cancer 17
- PI3K/AKT/mTOR signaling in cancer 5
-
- Diabetes and associated disorders 13
-
- Autophagy in Disease and Therapy 7
-
- Cannabis and Cannabinoid Research 5
- Co-authors
- Erol CerasiΝ. KaiserNurit KaiserYafa AriavDavid J. GrossMali Ketzinel‐GiladFred LevineEtty Bachar-Wikström
- Partner nations
- IsraelUnited StatesSweden
In The Last Decade
Gil Leibowitz
53 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 106
- Endocrinology, Diabetes and Metabolism 885
- Surgery 1.5k
- Physiology 120
- Cell Biology 420
- Physiology 579
Countries citing papers authored by Gil Leibowitz
This map shows the geographic impact of Gil Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Leibowitz more than expected).
Fields of papers citing papers by Gil Leibowitz
This network shows the impact of papers produced by Gil Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Leibowitz. The network helps show where Gil Leibowitz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gil Leibowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2021 | 11 | |
| 3 | 2021 | 16 | |
| 4 | 2018 | 15 | |
| 5 | 2017 | 65 | |
| 6 | 2016 | 28 | |
| 7 | 2014 | 79 | |
| 8 | 2012 | 34 | |
| 9 | 2009 | 44 | |
| 10 | 2009 | 11 | |
| 11 | 2008 | 61 | |
| 12 | 2006 | 23 | |
| 13 | 2003 | 172 | |
| 14 | 2002 | 30 | |
| 15 | Diabète de type 2 et apoptose des cellules b | 2000 | 16 |
| 16 | 1999 | 38 | |
| 17 | 1997 | 42 | |
| 18 | 1996 | 137 | |
| 19 | 1996 | 8 | |
| 20 | 1995 | 4 |
About Gil Leibowitz
Gil Leibowitz is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cell Biology, having authored 53 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (38 papers), Metabolism, Diabetes, and Cancer (17 papers), Diabetes and associated disorders (13 papers), Diabetes Management and Research (8 papers), Endoplasmic Reticulum Stress and Disease (7 papers), Autophagy in Disease and Therapy (7 papers), Cannabis and Cannabinoid Research (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (885 citations), Surgery (1.5k citations) and Physiology (120 citations). Gil Leibowitz has collaborated with scholars based in Israel, United States and Sweden. Frequent co-authors include Erol Cerasi, Ν. Kaiser, Nurit Kaiser, Yafa Ariav, David J. Gross, Mali Ketzinel‐Gilad, Fred Levine, Etty Bachar-Wikström, Jakob D. Wikström and Satoshi Naruse. Their work appears in journals such as Diabetologia, Diabetes, Endocrinology, Clinical Endocrinology and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.